At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02142 HBM HOLDINGS-B
Trading 06-09 15:22:10
9.810
-0.390
-3.82%
High10.020Low9.460Vol4.19M
Open10.020D1 Closing10.200Amplitude5.49%
Mkt Cap8.52BTradable Cap8.52BTotal Shares868.00M
T/O40.63MT/O Rate0.48%Tradable Shares868.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
HBM Holdings-B Completes HK$74.90 Million Share Buyback in May; Outstanding Share Count Drops by 5.24 Million
Bulletin Express  ·  06-04
HBM Holdings-B Completes HK$74.90 Million Share Buyback in May; Outstanding Share Count Drops by 5.24 Million
HBM HOLDINGS-B Shares Surge Over 5% on Positive Preclinical Data for AI-Derived Drug Candidate
Stock News  ·  06-04
HBM HOLDINGS-B Shares Surge Over 5% on Positive Preclinical Data for AI-Derived Drug Candidate
HBM Holdings (SEHK:2142) Valuation Check After Positive LET003 Obesity Antibody Preclinical Data
Simply Wall St.  ·  05-26
HBM Holdings (SEHK:2142) Valuation Check After Positive LET003 Obesity Antibody Preclinical Data
HBM Holdings Reports Share Repurchase and Share Award Issuance on 21 May 2026
Bulletin Express  ·  05-21
HBM Holdings Reports Share Repurchase and Share Award Issuance on 21 May 2026
HBM HOLDINGS-B (02142) Spends HK$2.3846 Million on Share Buyback of 200,000 Shares on May 21
Stock News  ·  05-21
HBM HOLDINGS-B (02142) Spends HK$2.3846 Million on Share Buyback of 200,000 Shares on May 21
HBM Holdings Cuts Float by 300,000 Shares, Issues 16,000 Award Shares; Treasury Stock Climbs to 31.63 Million
Bulletin Express  ·  05-20
HBM Holdings Cuts Float by 300,000 Shares, Issues 16,000 Award Shares; Treasury Stock Climbs to 31.63 Million
HBM Holdings-B (02142) Spends HK$6.15 Million on Share Buyback on May 19
Stock News  ·  05-19
HBM Holdings-B (02142) Spends HK$6.15 Million on Share Buyback on May 19
HBM Holdings files HKEX disclosure, repurchases shares at HKD 12.31 each
Reuters  ·  05-19
HBM Holdings files HKEX disclosure, repurchases shares at HKD 12.31 each
HBM HOLDINGS-B (02142) Invests HK$12.51 Million in Share Buyback on May 18
Stock News  ·  05-18
HBM HOLDINGS-B (02142) Invests HK$12.51 Million in Share Buyback on May 18
HBM Holdings-B repurchases 1.00 million shares for HK$12.51 million and issues 25,000 award shares
Bulletin Express  ·  05-18
HBM Holdings-B repurchases 1.00 million shares for HK$12.51 million and issues 25,000 award shares
Registration Open for "Zhihui Financial 2026 Summer Roadshow Conference"
Stock News  ·  05-18
Registration Open for "Zhihui Financial 2026 Summer Roadshow Conference"
HBM Holdings' Obesity Drug Found to Have Favorable Profile in Preclinical Data
MT Newswires Live  ·  05-18
HBM Holdings' Obesity Drug Found to Have Favorable Profile in Preclinical Data
HBM HOLDINGS-B (02142) Discloses Preclinical Data for LET003, a Next-Generation ACVR2A/2B Antibody Candidate for Obesity Treatment
Stock News  ·  05-18
HBM HOLDINGS-B (02142) Discloses Preclinical Data for LET003, a Next-Generation ACVR2A/2B Antibody Candidate for Obesity Treatment
Harbour Biomed Announces Promising Preclinical Data for Let003, Its First AI-Enabled Drug Candidate
THOMSON REUTERS  ·  05-18
Harbour Biomed Announces Promising Preclinical Data for Let003, Its First AI-Enabled Drug Candidate
HBM Holdings unveils strong pre-clinical results for AI-designed obesity antibody LET003
Bulletin Express  ·  05-18
HBM Holdings unveils strong pre-clinical results for AI-designed obesity antibody LET003
HBM HOLDINGS-B Spends HK$5.086 Million on Share Repurchase
Stock News  ·  05-15
HBM HOLDINGS-B Spends HK$5.086 Million on Share Repurchase
HBM Holdings files HKEX return disclosing share repurchase at HKD 12.72 each
Reuters  ·  05-15
HBM Holdings files HKEX return disclosing share repurchase at HKD 12.72 each
HBM Holdings-B Allocates HK$5.1021 Million for Share Buyback on May 14
Stock News  ·  05-14
HBM Holdings-B Allocates HK$5.1021 Million for Share Buyback on May 14
HBM Holdings files HKEX return disclosing share repurchase at HKD 12.76 each
Reuters  ·  05-14
HBM Holdings files HKEX return disclosing share repurchase at HKD 12.76 each
HBM Holdings Executes HKD 8.92 Million Share Buyback and Issues 25,000 Award Shares
Bulletin Express  ·  05-13
HBM Holdings Executes HKD 8.92 Million Share Buyback and Issues 25,000 Award Shares

Introduction

Company Name.
HBM HOLDINGS-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Hbm Holdings Ltd is an investment holding company primarily engaged in the business of developing innovative therapeutics in the fields of immuno-oncology and immunology diseases. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The Company provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.
Issue price:
--